Appelhans Dannielle

CEO and President at Rubius Therapeutics, Inc.

Sold, on record
$7k
Dollars the filings state
Form 4 sales
3
Latest Feb 24, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale Rubius Therapeutics, Inc.Unusual
    Aug 10, 2022 2022

    Sold 5,737 shares at $0.80 ($5k)

    Appelhans Dannielle, Chief Operating Officer

    Sold 45.9% of holdings ($10k position)6,763 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Rubius Therapeutics, Inc.Unusual
    Feb 1, 2023 +175 days

    Sold 3,878 shares at $0.25 ($970)

    Appelhans Dannielle, CEO and President

    Sold 27.2% of holdings ($4k position)10,385 shares leftFiling

  3. 3 Form 4 sale Rubius Therapeutics, Inc.Unusual
    Feb 24, 2023 +23 days

    Sold 10,385 shares at $0.13 ($1k)

    Appelhans Dannielle, CEO and President

    Sold 100% of holdings ($1k position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Appelhans Dannielle
Source
Feb 24, 2023Feb 27, 2023Rubius Therapeutics, Inc.CEO and PresidentForm 4 sale10,385$1k100.0%UnusualSEC
Feb 1, 2023Feb 1, 2023Rubius Therapeutics, Inc.CEO and PresidentForm 4 sale3,878$97027.2%UnusualSEC
Aug 10, 2022Aug 12, 2022Rubius Therapeutics, Inc.Chief Operating OfficerForm 4 sale5,737$5k45.9%UnusualSEC